Zexuan Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zexuan Yang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
J. Xi
Department of Ultrasound, Chengdu Women's and Children's Central Hospital, School of Medicine University of Electronic Science and Technology of China Chengdu Sichuan People's Republic of China
2 shared publications- Liuying Zhou
Department of Ultrasound, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan
2 shared publications - Yonghong Lin
Department of Gynecology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China
2 shared publications F. Liu
Department of Ultrasound, Chengdu Women's and Children's Central Hospital, School of Medicine University of Electronic Science and Technology of China Chengdu Sichuan The People's Republic of China (PRC)
1 shared publication- Fengqin Liu
Department of Ultrasound, Chengdu Women's and Children's Central Hospital School of Medicine, University of Electronic Science and Technology of China Chengdu China
1 shared publication - Jun Chen
Division of Pulmonary Diseases, State Key Laboratory of Biotherapy, and Department of Respiratory and Critical Care Medicine, and Center for High Altitude Medicine, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, People’s Republic of China
1 shared publication
Latest Publications
- 11 May 2023
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 61 (6) , 667-681
Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: systematic review and meta‐analysis
Objective: It is debated whether fetal endoscopic tracheal occlusion (FETO) is beneficial to fetuses with congenital diaphragmatic hernia (CDH) and whether FETO has different effects in moderate and severe CDH. We conducted a systematic review and meta‐analysis including the latest evidence to assess the overall effects of FETO on clinical outcomes of CDH.Methods: We searched PubMed, EMBASE, The Cochrane Library, China National Knowledge Infrastructure, China Science and Technology Journal Database and Wanfang Database to retrieve eligible studies published before 8 September 2022. No language or study design restrictions were applied. Studies were included if CDH fetuses underwent FETO surgery and were compared with a cohort that underwent expectant management, with at least one outcome reported. The primary outcomes were mortality at 1, 6 and 12 months after birth, rates of pulmonary hypertension, use of extracorporeal membrane oxygenation (ECMO) and prematurity. Meta‐analysis was conducted to obtain pooled odds ratios (ORs) and mean differences. The quality of included studies and pooled evidence was also assessed.Results: A total of 1187 CDH fetuses from 20 studies were included in the quantitative synthesis. FETO significantly reduced 1‐month (OR, 0.56 (95% CI, 0.34–0.93); P = 0.02, number needed to treat (NNT) = 7.67) and 6‐month (OR, 0.34 (95% CI, 0.18–0.65); P = 0.0009, NNT = 5.26) CDH mortality (moderate/low quality of evidence). Subgroup analysis suggested that the effects of FETO on the rates of pulmonary hypertension and ECMO usage were significant in severe CDH (low/moderate quality of evidence) but not in moderate CDH (low/very low quality of evidence). FETO was also associated with an increased risk of preterm prelabor rupture of membranes before 37 weeks' gestation (OR, 4.94 (95% CI, 2.25–10.88); P < 0.0001, number needed to harm (NNH) = 3.13) and preterm birth before 37 weeks (OR, 5.24 (95% CI, 3.33–8.23); P < 0.00001, NNH = 2.79) (high/moderate quality of evidence). However, FETO was not associated with severe complications, such as preterm birth before 32 weeks, placental abruption or chorioamnionitis (very low/low quality of evidence).Conclusions: FETO is associated with a reduction in mortality, rate of pulmonary hypertension and ECMO usage in severe CDH, while it reduces only the risk of mortality in moderate CDH. Although FETO increases the risk of late prematurity, it does not result in extreme prematurity. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
- 11 May 2023
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 61 (6) , 667-681
Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: systematic review and meta‐analysis
Objective: It is debated whether fetal endoscopic tracheal occlusion (FETO) is beneficial to fetuses with congenital diaphragmatic hernia (CDH) and whether FETO has different effects in moderate and severe CDH. We conducted a systematic review and meta‐analysis including the latest evidence to assess the overall effects of FETO on clinical outcomes of CDH.Methods: We searched PubMed, EMBASE, The Cochrane Library, China National Knowledge Infrastructure, China Science and Technology Journal Database and Wanfang Database to retrieve eligible studies published before 8 September 2022. No language or study design restrictions were applied. Studies were included if CDH fetuses underwent FETO surgery and were compared with a cohort that underwent expectant management, with at least one outcome reported. The primary outcomes were mortality at 1, 6 and 12 months after birth, rates of pulmonary hypertension, use of extracorporeal membrane oxygenation (ECMO) and prematurity. Meta‐analysis was conducted to obtain pooled odds ratios (ORs) and mean differences. The quality of included studies and pooled evidence was also assessed.Results: A total of 1187 CDH fetuses from 20 studies were included in the quantitative synthesis. FETO significantly reduced 1‐month (OR, 0.56 (95% CI, 0.34–0.93); P = 0.02, number needed to treat (NNT) = 7.67) and 6‐month (OR, 0.34 (95% CI, 0.18–0.65); P = 0.0009, NNT = 5.26) CDH mortality (moderate/low quality of evidence). Subgroup analysis suggested that the effects of FETO on the rates of pulmonary hypertension and ECMO usage were significant in severe CDH (low/moderate quality of evidence) but not in moderate CDH (low/very low quality of evidence). FETO was also associated with an increased risk of preterm prelabor rupture of membranes before 37 weeks' gestation (OR, 4.94 (95% CI, 2.25–10.88); P < 0.0001, number needed to harm (NNH) = 3.13) and preterm birth before 37 weeks (OR, 5.24 (95% CI, 3.33–8.23); P < 0.00001, NNH = 2.79) (high/moderate quality of evidence). However, FETO was not associated with severe complications, such as preterm birth before 32 weeks, placental abruption or chorioamnionitis (very low/low quality of evidence).Conclusions: FETO is associated with a reduction in mortality, rate of pulmonary hypertension and ECMO usage in severe CDH, while it reduces only the risk of mortality in moderate CDH. Although FETO increases the risk of late prematurity, it does not result in extreme prematurity. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
- 1 November 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 60 (5) , 700-702
Craniopagus and rachipagus conjoined twins in triplet pregnancy: challenges in early prenatal diagnosis at 12 weeks
- 1 November 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 60 (5) , 700-702
Craniopagus and rachipagus conjoined twins in triplet pregnancy: challenges in early prenatal diagnosis at 12 weeks
- 1 March 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 60 (2) , 292-294
Non‐visualization of choroid plexus in the fourth ventricle as first‐trimester abnormal clue in Noonan syndrome with agenesis of corpus callosum
- 1 March 2022
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 60 (2) , 292-294
Non‐visualization of choroid plexus in the fourth ventricle as first‐trimester abnormal clue in Noonan syndrome with agenesis of corpus callosum
- 31 August 2019
- Published by Wiley in Echocardiography
- Vol. 36 (10) , 1952-1955
Right aortic arch with mirror image branching accompanied by absent pulmonary valve syndrome and tricuspid stenosis: Prenatal echocardiographic diagnosis of an unusual congenital heart defect
Right aortic arch (RAA) with mirror image branching (RAMI) accompanied by absent pulmonary valve syndrome (APVS), tricuspid stenosis, and hypoplastic right ventricle is an extremely rare combination of congenital heart anomalies. This combination might result in severe cardiac failure and respiratory compromise, indicating a poor prognosis. Here, we describe a detailed prenatal echocardiographic diagnosis of RAMI accompanied by APVS and tricuspid stenosis. These anomalies were further confirmed by autopsy. This case could be helpful in improving our understanding of this abnormal combination and the development of an early therapeutic strategy.
- 31 August 2019
- Published by Wiley in Echocardiography
- Vol. 36 (10) , 1952-1955
Right aortic arch with mirror image branching accompanied by absent pulmonary valve syndrome and tricuspid stenosis: Prenatal echocardiographic diagnosis of an unusual congenital heart defect
Right aortic arch (RAA) with mirror image branching (RAMI) accompanied by absent pulmonary valve syndrome (APVS), tricuspid stenosis, and hypoplastic right ventricle is an extremely rare combination of congenital heart anomalies. This combination might result in severe cardiac failure and respiratory compromise, indicating a poor prognosis. Here, we describe a detailed prenatal echocardiographic diagnosis of RAMI accompanied by APVS and tricuspid stenosis. These anomalies were further confirmed by autopsy. This case could be helpful in improving our understanding of this abnormal combination and the development of an early therapeutic strategy.